Jasper Hellweg
Stock Analyst at Argus Research
(2.15)
# 2,817
Out of 4,945 analysts
87
Total ratings
47.89%
Success rate
3.69%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Downgrades: Hold | n/a | $134.94 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $312.06 | +28.18% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $100.09 | +49.87% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $49.04 | +22.35% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $565.97 | +106.72% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $390.30 | +40.92% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $78.47 | +8.32% | 3 | May 30, 2024 | |
| NVO Novo Nordisk | Maintains: Buy | $115 → $125 | $50.95 | +145.34% | 1 | Feb 1, 2024 | |
| MRNA Moderna | Maintains: Buy | $160 → $140 | $26.69 | +424.54% | 4 | Sep 13, 2023 | |
| ABBV AbbVie | Downgrades: Hold | n/a | $204.68 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $200 | $153.06 | +30.67% | 6 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.54 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $189.40 | +53.12% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $106.77 | -6.34% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $271.25 | +8.76% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.82 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $178.44 | -24.34% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $24.45 | - | 2 | Sep 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $23.03 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $248.07 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $41.19 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $393.65 | -60.62% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $134.62 | -33.15% | 1 | Sep 19, 2018 |
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $134.94
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $312.06
Upside: +28.18%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $100.09
Upside: +49.87%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $49.04
Upside: +22.35%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $565.97
Upside: +106.72%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $390.30
Upside: +40.92%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $78.47
Upside: +8.32%
Novo Nordisk
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $50.95
Upside: +145.34%
Moderna
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $26.69
Upside: +424.54%
AbbVie
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $204.68
Upside: -
Jun 17, 2022
Maintains: Buy
Price Target: $225 → $200
Current: $153.06
Upside: +30.67%
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $17.54
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $189.40
Upside: +53.12%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $106.77
Upside: -6.34%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $271.25
Upside: +8.76%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.82
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $178.44
Upside: -24.34%
Sep 4, 2020
Downgrades: Hold
Price Target: n/a
Current: $24.45
Upside: -
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $23.03
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $248.07
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $41.19
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $393.65
Upside: -60.62%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $134.62
Upside: -33.15%